Brokerages forecast that Danaher Co. (NYSE:DHR) will report sales of $4.79 billion for the current quarter, according to Zacks Investment Research. Six analysts have made estimates for Danaher’s earnings, with the highest sales estimate coming in at $4.84 billion and the lowest estimate coming in at $4.76 billion. Danaher reported sales of $4.70 billion during the same quarter last year, which indicates a positive year-over-year growth rate of 1.9%. The company is expected to announce its next earnings results before the market opens on Thursday, April 18th.

On average, analysts expect that Danaher will report full year sales of $20.33 billion for the current fiscal year, with estimates ranging from $19.71 billion to $20.52 billion. For the next year, analysts expect that the business will post sales of $21.47 billion, with estimates ranging from $21.32 billion to $21.97 billion. Zacks’ sales calculations are an average based on a survey of sell-side analysts that that provide coverage for Danaher.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, January 29th. The conglomerate reported $1.28 earnings per share for the quarter, beating analysts’ consensus estimates of $1.27 by $0.01. Danaher had a return on equity of 11.64% and a net margin of 13.33%. The company had revenue of $5.40 billion for the quarter, compared to the consensus estimate of $5.33 billion. During the same period in the previous year, the business earned $1.19 earnings per share. The company’s quarterly revenue was up 6.2% on a year-over-year basis.

DHR has been the subject of a number of research reports. Zacks Investment Research upgraded Danaher from a “hold” rating to a “buy” rating and set a $147.00 price objective for the company in a research report on Tuesday. Needham & Company LLC reissued a “buy” rating and set a $138.00 price target (up from $114.00) on shares of Danaher in a research note on Thursday, February 28th. Jefferies Financial Group boosted their price target on Danaher to $140.00 and gave the stock a “buy” rating in a report on Tuesday, February 26th. Deutsche Bank raised their price objective on shares of Danaher to $130.00 and gave the company a “buy” rating in a report on Tuesday, February 26th. Finally, UBS Group boosted their target price on shares of Danaher from $125.00 to $144.00 and gave the stock a “buy” rating in a report on Tuesday, February 26th. One research analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. Danaher currently has an average rating of “Buy” and a consensus price target of $125.46.

In other news, Director Walter G. Lohr sold 10,578 shares of Danaher stock in a transaction dated Wednesday, February 27th. The stock was sold at an average price of $126.85, for a total transaction of $1,341,819.30. Following the completion of the sale, the director now owns 20,691 shares in the company, valued at approximately $2,624,653.35. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Angela S. Lalor sold 4,534 shares of the business’s stock in a transaction dated Wednesday, February 27th. The stock was sold at an average price of $127.25, for a total value of $576,951.50. Following the transaction, the senior vice president now directly owns 21,209 shares of the company’s stock, valued at approximately $2,698,845.25. The disclosure for this sale can be found here. Insiders sold a total of 183,150 shares of company stock worth $23,279,637 over the last 90 days. Corporate insiders own 11.90% of the company’s stock.

Institutional investors and hedge funds have recently made changes to their positions in the stock. Laurel Wealth Advisors LLC purchased a new stake in Danaher during the 4th quarter valued at $27,000. CX Institutional lifted its stake in shares of Danaher by 188.7% during the 1st quarter. CX Institutional now owns 205 shares of the conglomerate’s stock valued at $27,000 after buying an additional 134 shares in the last quarter. Hanson McClain Inc. boosted its holdings in Danaher by 852.9% in the 4th quarter. Hanson McClain Inc. now owns 324 shares of the conglomerate’s stock worth $33,000 after buying an additional 290 shares during the period. Executive Wealth Management LLC bought a new position in Danaher in the 4th quarter worth $39,000. Finally, Ruggie Capital Group bought a new position in shares of Danaher in the fourth quarter worth about $40,000. 77.58% of the stock is currently owned by institutional investors and hedge funds.

Shares of DHR stock traded down $0.12 on Tuesday, reaching $131.83. 1,957,412 shares of the stock were exchanged, compared to its average volume of 2,958,014. The company has a market cap of $94.18 billion, a P/E ratio of 29.17, a PEG ratio of 2.41 and a beta of 1.04. Danaher has a one year low of $94.59 and a one year high of $134.50. The company has a quick ratio of 1.07, a current ratio of 1.47 and a debt-to-equity ratio of 0.34.

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 26th. Shareholders of record on Friday, March 29th will be paid a $0.17 dividend. This is a positive change from Danaher’s previous quarterly dividend of $0.16. This represents a $0.68 dividend on an annualized basis and a yield of 0.52%. The ex-dividend date of this dividend is Thursday, March 28th. Danaher’s dividend payout ratio is currently 15.04%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Further Reading: What are defining characteristics of a correction?

Get a free copy of the Zacks research report on Danaher (DHR)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with's FREE daily email newsletter.